FACTA-FARMA
0840.593.684 · rovalta.com · 25/09/2026
NORMAL SITUATION
FACTA-FARMA
Company — Normal situation.
Financial year 2025 · Closed on 31/12/2025
Net result-71,2 k €-174,9 %over 1 year
Gross margin21,4 k €-85,1 %over 1 year
Equity766,9 k €-8,5 %over 1 year
Workforce0,0 ETP
Overview
Identity
Source · BCE/KBOFACTA-FARMA is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0840.593.684
- Legal form
- Private limited company
- Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
- Average workforce
- 0,0 ETP
Signals
Solid equityGood liquidityPositive EBITDA
Financials
Source · NBB, 14 filingsTrend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 21,4 k € | -85.1% | 143,8 k € | +3.5% | 138,9 k € | +0.8% | 137,8 k € | -0.7% | 138,8 k € |
| EBITDA | 19,4 k € | -86.2% | 141 k € | +2.6% | 137,5 k € | +0.6% | 136,7 k € | -1.3% | 138,5 k € |
| Operating result | 19,4 k € | -86.2% | 141 k € | +2.6% | 137,5 k € | +0.6% | 136,7 k € | +1.2% | 135 k € |
| Net result | -71,2 k € | -175% | 95,1 k € | +3.6% | 91,7 k € | +11.8% | 82 k € | +2.5% | 80 k € |
| Balance sheet | |||||||||
| Equity | 766,9 k € | -8.5% | 838,1 k € | +3.1% | 813,1 k € | +12.7% | 721,4 k € | +12.8% | 639,3 k € |
| Total assets | 779,1 k € | -40.2% | 1,3 M € | -3.2% | 1,3 M € | +2.4% | 1,3 M € | +1.2% | 1,3 M € |
| Cash | 776,6 k € | +457% | 139,5 k € | -23.0% | 181,2 k € | +24.5% | 145,6 k € | +17.1% | 124,3 k € |
| Debts | 9 k € | -98.1% | 463,8 k € | -12.8% | 531,7 k € | -10.3% | 592,5 k € | -10.1% | 658,8 k € |
| Other | |||||||||
| Workforce | 0,0 ETP | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Karen Van Hoorickx
ActiveEnded mandates
Karen Van Hoorickx
EndedKaren Van Hoorickx
EndedKaren Van Hoorickx
EndedFinancials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Micro model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 11/02/2026 | 12/08/2025 | 02/08/2024 | 09/11/2023 | 10/10/2022 | 24/08/2021 |
| General meeting | 09/02/2026 | 02/06/2025 | 17/06/2024 | 06/11/2023 | 20/06/2022 | 21/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 14 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 09/02/2026 | 11/02/2026 | Dutch | |
| Abridged model | 31/12/2024 | 02/06/2025 | 12/08/2025 | Dutch | |
| Abridged model | 31/12/2023 | 17/06/2024 | 02/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 06/11/2023 | 09/11/2023 | Dutch | |
| Micro model | 31/12/2021 | 20/06/2022 | 10/10/2022 | Dutch | |
| Abridged model | 31/12/2020 | 21/06/2021 | 24/08/2021 | Dutch | |
| Abridged model | 31/12/2019 | 22/06/2020 | 04/09/2020 | Dutch | |
| Abridged model | 31/12/2018 | 17/06/2019 | 14/08/2019 | Dutch | |
| Micro model | 31/12/2017 | 18/06/2018 | 17/08/2018 | Dutch | |
| Micro model | 31/12/2016 | 19/06/2017 | 17/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 20/06/2016 | 30/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 22/06/2015 | 29/07/2015 | Dutch | |
| Abridged model | 31/12/2013 | 08/05/2014 | 29/07/2014 | Dutch | |
| Abridged model | 31/12/2012 | 24/05/2013 | 23/07/2013 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 3 ended
Active mandates
Karen Van Hoorickx
ActiveEnded mandates
Karen Van Hoorickx
EndedKaren Van Hoorickx
EndedKaren Van Hoorickx
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution09/04/2026RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ...
- Mandates16/05/2025STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Registered office20/03/2014MAATSCHAPPELIJKE ZETEL
- Other09/11/2011RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025-71,2 k €↓
- 2024Annual accounts 202495,1 k €↑
- 2023Annual accounts 202391,7 k €↑
- 2022Annual accounts 202282 k €↑
- 2021Annual accounts 202180 k €↓
- 2020Annual accounts 202082,9 k €↓
- 2019Annual accounts 201985,7 k €↓
- 2018Annual accounts 201897,5 k €↑
- 2017Annual accounts 201783,2 k €↑
- 2016Annual accounts 201673 k €↑
- 2015Annual accounts 201568 k €↑
- 2014Annual accounts 201463,5 k €↑
- 2013Annual accounts 201331,9 k €↑
- 2012Annual accounts 20124,9 k €